Tevogen Bio Holdings Financial Overview
Tevogen Bio Holdings's market cap is currently $75.44M. The company's EPS TTM is $-0.03; its P/E ratio is -2.17; Tevogen Bio Holdings is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
